Collage of published research papers

Citation

BibTex format

@article{Rowan:2021:10.1016/j.jviromet.2021.114174,
author = {Rowan, AG and May, P and Badhan, A and Herrera, C and Watber, P and Penn, R and Crone, MA and Storch, M and Garson, JA and McClure, M and Freemont, PS and Madona, P and Randell, P and Taylor, GP},
doi = {10.1016/j.jviromet.2021.114174},
journal = {Journal of Virological Methods},
pages = {1--7},
title = {Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control.},
url = {http://dx.doi.org/10.1016/j.jviromet.2021.114174},
volume = {294},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - There is growing evidence that measurement of SARS-CoV-2 viral copy number can inform clinical and public health management of SARS-CoV-2 carriers and COVID-19 patients. Here we show that quantification of SARS-CoV-2 is feasible in a clinical setting, using a duplex RT-qPCR assay which targets both the E gene (Charité assay) and a human RNA transcript, RNase P (CDC assay) as an internal sample sufficiency control. Samples in which RNase P is not amplified indicate that sample degradation has occurred, PCR inhibitors are present, RNA extraction has failed or swabbing technique was insufficient. This important internal control reveals that 2.4% of nasopharyngeal swabs (15/618 samples) are inadequate for SARS-CoV-2 testing which, if not identified, could result in false negative results. We show that our assay is linear across at least 7 logs and is highly reproducible, enabling the conversion of Cq values to viral copy numbers using a standard curve. Furthermore, the SARS-CoV-2 copy number was independent of the RNase P copy number indicating that the per-swab viral copy number is not dependent on sampling- further allowing comparisons between samples. The ability to quantify SARS-CoV-2 viral copy number will provide an important opportunity for viral burden-guided public health and clinical decision making.
AU - Rowan,AG
AU - May,P
AU - Badhan,A
AU - Herrera,C
AU - Watber,P
AU - Penn,R
AU - Crone,MA
AU - Storch,M
AU - Garson,JA
AU - McClure,M
AU - Freemont,PS
AU - Madona,P
AU - Randell,P
AU - Taylor,GP
DO - 10.1016/j.jviromet.2021.114174
EP - 7
PY - 2021///
SN - 0166-0934
SP - 1
TI - Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control.
T2 - Journal of Virological Methods
UR - http://dx.doi.org/10.1016/j.jviromet.2021.114174
UR - https://www.ncbi.nlm.nih.gov/pubmed/33984396
UR - https://www.sciencedirect.com/science/article/pii/S0166093421001130?via%3Dihub
UR - http://hdl.handle.net/10044/1/88654
VL - 294
ER -

Awards

  • Finalist: Best Paper - IEEE Transactions on Mechatronics (awarded June 2021)

  • Finalist: IEEE Transactions on Mechatronics; 1 of 5 finalists for Best Paper in Journal

  • Winner: UK Institute of Mechanical Engineers (IMECHE) Healthcare Technologies Early Career Award (awarded June 2021): Awarded to Maria Lima (UKDRI CR&T PhD candidate)

  • Winner: Sony Start-up Acceleration Program (awarded May 2021): Spinout company Serg Tech awarded (1 of 4 companies in all of Europe) a place in Sony corporation start-up boot camp

  • “An Extended Complementary Filter for Full-Body MARG Orientation Estimation” (CR&T authors: S Wilson, R Vaidyanathan)

UK DRI


Established in 2017 by its principal funder the Medical Research Council, in partnership with Alzheimer's Society and Alzheimer’s Research UK, The UK Dementia Research Institute (UK DRI) is the UK’s leading biomedical research institute dedicated to neurodegenerative diseases.